Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market
Jul 09 2019
•
By
Derrick Gingery
US FDA wants to increase the availability of naloxone, which is used for emergency opioid overdoses. • Source: Shutterstock
More from Generics
More from Biosimilars & Generics